Eurofins Scientific SE provided revenue guidance for the fiscal year 2024. For the year, the company expects revenue including M&A of 7,250 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58.26 EUR | -1.65% | +1.71% | -1.22% |
May. 13 | Eurofins Scientific to Expand US Battery Materials Testing Capabilities | MT |
May. 13 | Eurofins Scientific expands capacity in the USA | CF |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.22% | 12.42B | |
+19.28% | 84.52B | |
-26.95% | 72.21B | |
+4.65% | 27.74B | |
-7.35% | 17.97B | |
-0.46% | 17.46B | |
+4.69% | 15.82B | |
+8.14% | 13.55B | |
+6.59% | 13.31B | |
+70.00% | 12.5B |
- Stock Market
- Equities
- ERF Stock
- News Eurofins Scientific SE
- Eurofins Scientific SE Provides Revenue Guidance for the Fiscal Year 2024